ACST

Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement

[GlobeNewswire] – LAVAL, Quebec — Neptune Technologies & Bioressources Inc. (Neptune) and Acasti Pharma Inc. (Acasti) , a Neptune subsidiary, announce that a final and binding patent infringement … moreView todays social media effects on ACSTView the latest stocks trending across Twitter. Click to view dashboardSee who Acasti is hiring next, click here to view […]

April 28, 2014 Bystocknews ACST, stock Comments Off read more

Neptune and Enzymotec Conclude Final Patent Infringement Settlement ad License Agreement

[GlobeNewswire] – LAVAL, Quebec — Neptune Technologies & Bioressources Inc. (Neptune) and Acasti Pharma Inc. (Acasti) , a Neptune subsidiary, announce that a final and binding patent infringement … moreView todays social media effects on ACSTView the latest stocks trending across Twitter. Click to view dashboardSee who Acasti is hiring next, click here to view […]

April 28, 2014 Bystocknews ACST, stock Comments Off read more

Neptune and Enzymotec Conclude Final Patent Infringement Settlement and License Agreement

Neptune and Enzymotec Conclude Final Patent Infringement Settlement ad License Agreement

4 Stocks Under $10 to Trade for Breakouts

Nasdaq stocks posting largest volume increases

Krill Oil’s Omega-3s And CaPre: Brought To You By Acasti

3 Speculative Healthcare Companies With High Levels Of Insider Ownership – Part III

Amarin: The More You Know The Fishier It Gets

3 Speculative Healthcare Companies With Very High Insider Ownerships

Speculative Quasi-Biotech Neptune Off To A Strong Start In 2013

Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity